Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Bupropion ameliorates methamphetamine dependence in some patients

Dec. 28, 2007

Catalyst reports positive phase II trial results for vigabatrin for cocaine addiction

Dec. 11, 2007

HDAC5 function in nucleus accumbens altered by chronic cocaine and stress

Dec. 5, 2007

Low daily doses of rimonabant reduce responses to cannabis

Nov. 30, 2007

E.U. approves Merck Serono's Cyanokit for cyanide poisoning

Nov. 29, 2007

Tiagabine ineffective in cocaine dependence study

Nov. 22, 2007

DOR BioPharma enters cooperative agreement for RiVax with Walter Reed Army Institute

Nov. 21, 2007

Acrux initiates production of Nicotine MDTS following successful phase I clinical trial

Nov. 16, 2007

Aeolus's AEOL-10150 demonstrates protection against mustard gas

Nov. 12, 2007

Celtic Pharma completes enrollment in phase IIb TA-NIC study

Nov. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...